Clal Biotechnology Industries (XTAE:CBI) Days Inventory : 0.00 (As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

What is Clal Biotechnology Industries Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Clal Biotechnology Industries's Average Total Inventories for the three months ended in Dec. 2023 was ₪0.00 Mil. Clal Biotechnology Industries's Cost of Goods Sold for the three months ended in Dec. 2023 was ₪0.00 Mil.

The historical rank and industry rank for Clal Biotechnology Industries's Days Inventory or its related term are showing as below:

During the past 13 years, Clal Biotechnology Industries's highest Days Inventory was 133.20. The lowest was 2.99. And the median was 46.85.

XTAE:CBI's Days Inventory is not ranked ^*
in the Biotechnology industry.
Industry Median: 193.86
* Ranked among companies with meaningful Days Inventory only.

Clal Biotechnology Industries's Days Inventory declined from Jun. 2022 (36.16) to Dec. 2023 (0.00).

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Clal Biotechnology Industries Days Inventory Historical Data

The historical data trend for Clal Biotechnology Industries's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clal Biotechnology Industries Days Inventory Chart

Clal Biotechnology Industries Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Inventory

Get a 7-Day Free Trial

37.45

Clal Biotechnology Industries Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Jun23	Dec23
Days Inventory	Get a 7-Day Free Trial															36.16	-	-	-	-

Competitive Comparison of Clal Biotechnology Industries's Days Inventory

For the Biotechnology subindustry, Clal Biotechnology Industries's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Clal Biotechnology Industries's Days Inventory Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Clal Biotechnology Industries's Days Inventory distribution charts can be found below:

* The bar in red indicates where Clal Biotechnology Industries's Days Inventory falls into.

Clal Biotechnology Industries Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Clal Biotechnology Industries's Days Inventory for the fiscal year that ended in Dec. 2023 is calculated as

	Days Inventory (A: Dec. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (A: Dec. 2022 )	+	Total Inventories (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0	*	365
=	0					/	0	*	365
=	N/A

Clal Biotechnology Industries's Days Inventory for the quarter that ended in Dec. 2023 is calculated as:

	Days Inventory (Q: Dec. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (Q: Jun. 2023 )	+	Total Inventories (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0	*	365 / 4
=	0					/	0	*	365 / 4
=	N/A

Clal Biotechnology Industries (XTAE:CBI) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Clal Biotechnology Industries's Inventory Turnover for the three months ended in Dec. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0	/	0
	=

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Clal Biotechnology Industries's Inventory to Revenue for the three months ended in Dec. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	0	/	0
	=

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

Clal Biotechnology Industries Days Inventory Related Terms

Thank you for viewing the detailed overview of Clal Biotechnology Industries's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Clal Biotechnology Industries (XTAE:CBI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clal Biotechnology Industries Ltd (XTAE:CBI) » Definitions » Days Inventory

Comparable Companies

Traded in Other Exchanges

N/A

Address

Azrieli Center, Triangle Building, 45th Floor, Tel Aviv, ISR, 67023

Website

http://www.cbi.co.il

Clal Biotechnology Industries Ltd is a life sciences investment company. The company invests in companies ranging from seed to maturity, both public and private. Its portfolio of investments includes from heavy industry to biotechnology, hi-tech and energy companies.